Scinai Immunotherapeutics (SCNI) Return on Assets (2020 - 2026)

Scinai Immunotherapeutics (SCNI) posted Return on Assets of 0.0% for Q1 2026, up 32.37% sequentially from 0.01% in Q4 2025.

Scinai Immunotherapeutics (SCNI) Return on Assets (2020 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Return on Assets for 7 years, with the latest figure at 0.0% in Q1 2026.

Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.03%, down 1.0% from the prior year.
Return on Assets advanced to 0.0% in Q1 2026 per SCNI's latest filing, from 0.01% in the prior quarter.
Over five years, Return on Assets peaked at 0.01% in Q3 2022 and troughed at 0.01% in Q3 2023.
A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
The sharpest annual moves came in 2023 and 2024: Return on Assets declined 2 bps in 2023, then rose 1 bps in 2024.
Over 5 years, Return on Assets stood at 0.0% in 2022, then decreased by 3 bps to 0.0% in 2023, then jumped by 148 bps to 0.0% in 2024, then tumbled by 398 bps to 0.01% in 2025, then surged by 32 bps to 0.0% in 2026.
According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.01%, and 0.0% for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	0.00%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	0.00%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	0.00%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	0.00%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	0.00%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.00%
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	0.00%
10	Scinai Immunotherapeutics	1.08 Mn	-3.11 Bn	-1.12 Mn	0.00%

Download Data